Bioinformatic analysis reveals GSG2 as a potential target for breast cancer therapy

Affiliations

Ye Zheng: Tianjin Key Laboratory of Medical Epigenetics; Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education); Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China
Zhang Zhaoyu: Tianjin Key Laboratory of Medical Epigenetics; Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education); Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China
Fang Lijiao: Tianjin Key Laboratory of Medical Epigenetics; Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education); Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China
Tian Daiquan: Tianjin Chest Hospital, Tianjin 300222, China
Liu Xin: Department of Biochemistry and Molecular Biology, 22 Qixiangtai Road, Tianjin Medical University, Tianjin 300070, China

Abstract

To explore the potential role of GSG2 in breast cancer progression.